previous compound ID: 2270 next compound
InChIKey: UUVWYPNAQBNQJQ-UHFFFAOYSA-N
SMILES: CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "E Matthes" "J Goepp" "D Rotin" "DY Thomas" "JW Hanrahan" "GW Carlile" "R Robert" "B Kus" "J Liao"

chemical graph of compound 2270





CID is 2123
synonyms found at PubChem are:
altretamine, HEXAMETHYLMELAMINE, 645-05-6, Hexalen, Hexastat, Hemel, Altretamina, Altretaminum, Melamine, hexamethyl-, 2,4,6-Tris(dimethylamino)-1,3,5-triazine, Altretaminum [INN-Latin], ENT 50852, NC 195, NCI-C50259, 2,4,6-Tris(dimethylamino)-s-triazine, Altretamina [INN-Spanish], N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine, HMM, Altretamine (Hexalen), NSC 13875, HTM, HXM, s-Triazine, 2,4,6-tris(dimethylamino)-, UNII-Q8BIH59O7H, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-, Hexalen (TN), Altretamine [USAN:INN:BAN], CCRIS 5492, MLS000069621, N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine, C9H18N6, Altretamine (USP/INN), EINECS 211-428-4, BRN 0195058, Q8BIH59O7H, SMR000058181, AI3-50852, CHEBI:24564, UUVWYPNAQBNQJQ-UHFFFAOYSA-N, 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine, NSC13875, KB-913, NSC-13875, NCGC00015100-02, DSSTox_CID_2579, 2,4, 6-Tris(dimethylamino)-1,3,5-triazine, A 8723, DSSTox_RID_76641, DSSTox_GSID_22579, Hexinawas, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N',N'-hexamethyl-, N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine, CAS-645-05-6, SR-01000000117, Hexalen [Antineoplastic], hexylen, Altretamin, Altretamine/, No-s-triazine, HSDB 7559, Altretamine, solid, Altretamine [USAN:USP:INN:BAN], Hexalen, Altretamine, Spectrum_001308, Altretamine Bellon Brand, Altretamine Chiesi Brand, AC1L1CYX, Opera_ID_1095, Prestwick0_000946, Prestwick1_000946, Prestwick2_000946, Prestwick3_000946, Spectrum2_000907, Spectrum3_000951, Spectrum4_001064, Spectrum5_001092, Lopac-A-8723, 2,4,6-Tris(dimethylami, ChemDiv2_005185, D02LPF, Bellon Brand of Altretamine, Cambridge id 5148727, Chiesi Brand of Altretamine, cid_2123, SCHEMBL4206, Altretamine Wassermann Brand, CHEMBL1455, Lopac0_000083, BSPBio_000912, KBioGR_001388, KBioSS_001788, ZINC905, MLS001076123, DivK1c_000772, SPECTRUM1503065, SPBio_000754, SPBio_003071, BPBio1_001004, GTPL7112, Wassermann Brand of Altretamine, DTXSID4022579, BDBM37631, CTK8F7682, HMS502G14, KBio1_000772, KBio2_001788, KBio2_004356, KBio2_006924, KBio3_002042, MGI Pharma Brand of Altretamine, MolPort-002-111-210, NINDS_000772, BCPP000413, HMS1383L15, HMS1570N14, HMS1922C05, HMS2090G17, HMS2092H16, HMS2097N14, HMS2234F09, HMS3259I20, HMS3260A08, HMS3372H17, HMS3654H11, HMS3714N14, Pharmakon1600-01503065, BCP27675, CCG-2238, HY-B0181, KS-00001F6N, 2,6-Tris(dimethylamino)-s-triazine, Tox21_110085, Tox21_202784, Tox21_500083, ABP000596, ENT-50852, NSC758231, s1278, STK749184, 2,4,6-Tris(dimethylamino-s-triazine, s-Triazine,4,6-tris(dimethylamino)-, AKOS001729401, Tox21_110085_1, BCP9000278, CS-2061, DB00488, KS-5247, LP00083, LS-1549, MCULE-1605383293, NC00595, NSC-758231, RP18094, VA10242, IDI1_000772, IDI1_003900, NCGC00015100-01, NCGC00015100-03, NCGC00015100-04, NCGC00015100-05, NCGC00015100-06, NCGC00015100-07, NCGC00015100-08, NCGC00015100-09, NCGC00015100-10, NCGC00015100-11, NCGC00015100-12, NCGC00015100-14, NCGC00015100-15, NCGC00021216-03, NCGC00021216-04, NCGC00021216-05, NCGC00021216-06, NCGC00021216-07, NCGC00260330-01, NCGC00260768-01, Rhone Poulenc Rorer Brand of Altretamine, Rhone-Poulenc Rorer Brand of Altretamine, AC-12006, AN-47064, BC203873, CAS-654-05-6, CPD000058181, NCI60_000871, SAM002564241, SC-26614, ST086739, ZB000200, 2,6-Tris(dimethylamino)-1,3,5-triazine, SBI-0050071.P003, AB0007992, AB2000024, AB00052308, EU-0100083, FT-0083576, FT-0651499, D02841, M-2093, 49712-EP2295426A1, 49712-EP2295427A1, 49712-EP2308833A2, 49712-EP2311825A1, AB00052308-16, AB00052308-17, AB00052308-18, AB00052308_19, AB00052308_20, 645A056, A834788, WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1, 2,4,6-Tris(dimethylamino)-1,3,5-triazine, 96%, I06-0604, J-523408, SR-01000000117-2, SR-01000000117-4, SR-01000000117-6, BRD-K67043667-001-04-1, BRD-K67043667-001-15-7, Z57931197, 645-05-6,2975-00-0(HCl), A0567/0026158, Altretamine [2,4,6-Tris(dimethylamino)-1,3,5-triazine], [4,6-bis(dimethylamino)(1,3,5-triazin-2-yl)]dimethylamine, N2,N2,N4,N4,N6,N6-Hexamethyl-1,3,5-trazne-2,4,6-tramne, 1,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-, Altretamine, United States Pharmacopeia (USP) Reference Standard, N-[4,6-bis(dimethylamino)-1,3,5-triazin-2-yl]-N,N-dimethylamine, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'', N''-hexamethyl-, InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H